Photo by Chokniti Khongchum from Pexels
Few healthcare companies were included in the annual ranking of innovative companies from the analytics firm Clarivate plc (NYSE:CLVT).
Two companies in pharma and another in medtech, however, made the cut.
Johnson & Johnson was featured for the second consecutive year as a top 100 Global innovator.
Roche was included for the 11th consecutive year in the report.
In medtech, Philips was included for the second consecutive year.
Clarivate notes the fragmented nature of pharmaceutical research contributes to the limited number of companies in the ranking. Given the elevated role of academia and contract firms in drug discovery and development, it is more challenging for any single entity to stand out in the industry.
Additionally, Clarivate concluded that the ability of the pharmaceutical sector to innovate has fallen since last year. The firm projects that the level of innovation in the industry will continue to fall to 2023 and will then plateau until 2025.
Within the pharmaceutical industry, Clarivate cited the following companies as the most innovative:
| Top 20, Pharmaceuticals | Region | Country |
| Abbott | Americas | US |
| Abbvie | Americas | US |
| Amgen | Americas | US |
| AstraZeneca | EMEA | UK |
| Bayer | EMEA | Germany |
| Boehringer Ingelheim | EMEA | Germany |
| Bristol Myers Squibb | Americas | US |
| Eisai | APAC | Japan |
| Gilead Sciences | Americas | US |
| GlaxoSmithKline | EMEA | UK |
| Johnson & Johnson | Americas | US |
| Lilly | Americas | US |
| Merck Sharp & Dohme | Americas | US |
| Novartis | EMEA | Switzerland |
| Novo Nordisk | EMEA | Denmark |
| Otsuka Pharmaceutical | APAC | Japan |
| Pfizer | Americas | US |
| Roche | EMEA | Switzerland |
| Sanofi | EMEA | France |
| Takeda | Americas | Japan |